Hbc Financial Services, Pllc Bristol Myers Squibb CO Transaction History

Hbc Financial Services, Pllc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$61.91 - $67.42 $12,382 - $13,484	-200 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$59.34 - $66.74 $35,604 - $40,044	-600 Reduced 75.0%	200 $12,000
Q4 2020 Feb 08, 2021	BUY	$57.74 - $65.43 $10,739 - $12,169	186 Added 30.29%	800 $49,000
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $10,681 - $11,837	-186 Reduced 23.25%	614 $39,000
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $27,410 - $32,045	500 Added 166.67%	800 $47,000
Q1 2020 May 04, 2020	BUY	$46.4 - $67.43 $2,320 - $3,371	50 Added 20.0%	300 $16,000
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $12,302 - $16,047	250 New	250 $16,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Hbc Financial Services, Pllc, based on Form 13F filings with the SEC.

Stay updated on Hbc Financial Services, Pllc with notifications on news.